Aspire targets $300M personalized medical device fund
Aspire Universal is trying to raise a $300 million precision medicine fund to back personalized device firms. The fund will invest in companies that tap into artificial intelligence and the internet of things to deliver scalable devices tailored to the biology and lifestyle of individuals. Investment group Aspire and fellow general partner Penn Medicine Lancaster General Health (LG Health) have contributed a combined $30 million to the fund.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063